Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy

Journal of Autoimmunity

Volumn 11, Issue 6, 1998, Pages 591-601

  Qin, H Y ^a   Elliott, J F ^b   Lakey, J R T ^b   Rajotte, R V ^b   Singh, B ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Adjuvant; Autoimmunity; GAD; Immunoregulation; Th1; Th2

Indexed keywords

GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE; INTERLEUKIN 4;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; HUMORAL IMMUNITY; IMMUNOTHERAPY; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

EID: 0032414556     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1998.0243     Document Type: Article

References (41)

1. Zhang Z.J., Davidson L., Eisenbarth G., Weiner H.L. Suppression of diabetes in non-obese diabetic mice by oral administration of porcine insulin. Proc Natl Acad. Sci USA. 88:1991;10252-10256.
2. Atkinson M.A., Maclaren N.K., Luchetta R. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes. 39:1990;933-937.
3. Kauffman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S.P., Robinson P., Atkinson M.A., Sercarz E.E., Tobin A.J., Lehman P.V. Spontaneous loss of T cell tolerance to glutamic acid decarboxylase. Nature. 366:1993;69-72.
4. Tisch R., Yang Y.D., Singer S.M., Liblan R.S., Fugger L., McDevitt H.O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:1993;72-75.
5. Elliott J.F., Qin H-Y., Bhatti S., Smith D.K., Singh P.K., Dillon T., Lauzon J., Singh B. Immunization with large isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes. 43:1994;1494-1499.
6. Ma S.-W., Zhao D.-L., Yin Z.-Q., Mukherjee R., Singh B., Qin H.-Y., Stiller C.R., Jevnikar A.M. Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance. Nat. Med. 3:1997;793-797.
7. Elias D., Markovits D., Reshef T., Van der Zee R., Cohn I.F. Induction and therapy of autoimmune diabetes in the non-obese diabetes (NOD/LT) mouse by a 65 kDa heat shock protein. Proc. Natl. Acad. Sci. USA. 87:1990;1576-1580.
8. Tian J., Clare-Salzler M., Herschenfeld A., Middleton B., Newman D., Mueller R., Arita S., Evans C., Atkinson M., Mullen Y., Sarvetnick N., Tobin A.J., Lehmann P.V., Kaufman D.L. Modulating autoimmune response to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat. Med. 2:1996;1948-1953.
9. Elias D., Cohen R. Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277. Diabetes. 44:1995;1132-1138.
10. +. Immunol. Today. 16:1995;34-38.
11. Sadelain M.W.J., Qin H-Y., Somoski W., Parfrey N., Singh B., Rabinovitch A. Prevention of diabetes in the BB rat by early immunotherapy using Freunds adjuvant. J. Autoimmunity. 3:1990;671-680.
12. Sadelain M.W.J., Qin H-Y., Lauzon J., Singh B. Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes. 39:1990;583-589.
13. Yagi H., Matsumoto M., Suzuki S., Misaki S., Suzuki R., Makino S., Harada M. Possible mechanism of preventive effect of BCG against diabetes mellitus in NOD mice. Cell Immunol. 138:1991;130-141.
14. Shehadeh N., Calcinaro F., Bradley B.J., Bruchilm J., Vardi P., Lafferty K.J. Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet. 343:1993;706-707.
15. Singh B., Prange S., Jevnikar A. Protective and destructive effects of microbial infection in insulin-dependent diabetes mellitus. Sem. Immunol. 10:1998;79-86.
16. Powrie F., Coffman R.L. Cytokines regulation of T cell function: potential for therapeutic intervention. Immunol. Today. 14:1993;270-274.
17. Mosman T.R., Coffman R.L. Th1 and Th2 cells different leads to different functional properties. Ann. Rev. Immunol. 7:1989;145-173.
18. Rabinovitch A., Suarez-Pinzon W.L., Sorensen O., Bleackley R.C., Power R.F. IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells-corelates with autoimmune diabetes in nonobese diabetic mice. J. Immunol. 154:1995;4874-4882.
19. Rapport M.J., Jaramillo A., Zipris D., Lazarus A.H., Serreze D.V., Leiter E.H., Cyopick P., Danska S., Delovitch
20. Qin, H.-Y.,Elliott, J.,Lakey, J.R.T.,Rajotte, R.V.,Singh, B.1995Predominant Th2 cell response in NOD mice protected from diabetes by immunization with CFA, BCG or mouse glutamic acid decarboxylase (GAD67).The 9th International Congress of Immunology. July 1995, San Francisco, CA, USA, No. 4999.
21. Qin H-Y., Singh B. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide. J. Autoimmunity. 10:1997;271-278.
22. Ridgway W.M., Fasso M., Lanctot A., Garey C., Fathman C.G. Breaking self-tolerance in non-obese diabetic mice. J. Exp. Med. 183:1993;1657-1662.
23. Qin H.-Y., Sadelain M.W.J., Hichon C., Lauzon J., Singh B. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in non-obese diabetic mice. J. Immunol. 150:1993;2072-2080.
24. Wang T., Singh B., Warnock G.L., Rajotte R.V. Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes. 41:1992;114-117.
25. Lakey J.R.T., Singh B., Warnock G.L., Rajotte R.V. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into NOD mice. Transplantation. 57:1994;1213-1217.
26. Burstein H.J., Shea C.M., Abbas K. Aqueous antigen inducesin vivo. J. Immunol. 148:1993;3687-3691.
27. Evavold B., Allen P.M. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science. 252:1991;1308-1310.
28. Shehadeh N.N., La Rosa F., Lafferfty K.J. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmunity. 6:1993;291-296.
29. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., Gordon S.V., Eiglmeier K., Gas S., Barry C.E., III, Tekaia F., Badcock K., Basham D., Brown D., Chillingworth T., Connor R., Davies R., Devlin K., Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K., Krough A., McLean J., Moule S., Murphy L., Oliver K., Osborne J., Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton J., Squares S., Sulston J.E., Taylor K., Whitehead S., Barrell B.G. Deciphering the biology of mycobacterium tuberculosis from the complete genome sequence. Nature. 393:1998;537-544.
30. Smith D.K., Kassan T., Singh B., Elliott J.F. Escherichia coli. J. Bacteriol. 174:1992;5820-5826.
31. Jone D.B., Coulson A.F.W., Duff D.W. Sequence homologies between hsp60 and autoantigen. Immunol. Today. 14:1993;115-118.
32. Birk O.S., Elias D., Weiss A.S., Rosen A., Van der Zee R., Walker M.D., Cohen R. NOD mouse diabetes: the ubiquitous mouse hsp60 is a β-cell target antigen of autoimmune T cells. J. Immunol. 9:1996;159-166.
33. Tian J., Lehmann P.V., Kaufman D. T cell cross-reactivity between coxsackivirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J. Exp. Med. 180:1994;1979-1984.
34. +. J. Immunol. 149:1993;3157-3165.
35. Lenschow D.J., Herold K.C., Rhee L., Pate B., Qin H.-Y., Fuchs E., Singh B., Thompson C.Z., Bluestone A. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity. 5:1996;385-393.
36. Sander B., Skansen-Saphiru U., Danim O., Hakansson L., Anderson J., Anderson U. Sequential production of Th1 and Th2 cytokine in response to liveBacillus. Immunology. 4:1995;512-518.
37. Hancock W.W., Polanski M., Zhang J., Blogg N., Weiner H.I. Suppression of insulitis in non-obsese diabetes (NOD) by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-β and prostaglandin-E. Am. J. Pathol. 147:1995;1193-1199.
38. Singer S.M., Tish R., Yang X.D., McDevitt H.O. An I-Ad transgene prevents diabetes in non-obese diabetic mice inducing regulatory T cells. Proc Natl Acad Sci. USA. 90:1993;9566-9570.
39. Katz J.D., Benoist C., Mathis D. T helper subsets in insulin-dependent diabetes. Science. 268:1995;1185-1188.
40. Wogensen L., Lee M.S., Sarvetnick N. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in non-obese diabetes mice. J. Exp. Med. 179:1994;1379-1384.
41. Hanson M.S., Cetecovic-Cvrlje M., Rramiya V.K., Atkinson M.A., Maclaren N.K., Singh B., Elliott J.F., Serreze D.V., Leiter E.H. Quantitative thresholds of MHC class II I-E expressed on hematopoitically derived APC in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection. J. Immunol. 157:1996;1279-1287.